Side effects of tamoxifen are distressing and common

doi:10.1136/bmj.313.7070.1484b

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Amrit Ray,
Robert C F Leonard

Medical student Consultant medical oncologist Department of Clinical Oncology, Western General Hospital, Edinburgh EH4 2XU

EDITOR,—The letters by R D Bulbrook and Michael Baum and Jack Cuzick reflect the medical interest in the long term risks of prophylactic tamoxifen in ostensibly well women who are at risk of breast cancer as well as in the prevention or delay of relapse after surgery for symptomatic disease. …